About this trial
This prospective study aims to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) in characterizing adnexal cystic lesions and differentiating benign from malignant lesions. MRI findings will be correlated with histopathology, surgical data, laboratory results, or follow-up imaging when surgery is not performed, to improve diagnostic confidence and guide appropriate patient management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female patients of any age with adnexal cystic lesions detected by ultrasound
Adnexal lesions that are indeterminate or suspicious on ultrasound
Patients who provide written and oral informed consent
Disqualifiers
Patients unwilling to participate or complete the study
Contraindications to MRI, including claustrophobia, metallic implants, pacemaker, or prosthetic heart valves
Trial population
The study population will consist of 50 female patients of all ages presenting to the Radiology Department at Sohag University Hospital with adnexal cystic lesions detected on ultrasound. Eligible participants are those with indeterminate or suspicious ultrasound findings requiring further characterization with MRI. Patients will provide written and oral informed consent prior to inclusion.
Trial design
Cohort
Prospective
Treatments tested in this trial
Magnetic Resonance Imaging
Diagnostic testMagnetic resonance imaging (MRI) of the pelvis will be performed using 1.5T or 3T scanners with a phased-array pelvic coil. The protocol will include axial, sagittal, and coronal T2-weighted images, axial T1-weighted and fat-suppressed T1-weighted images, diffusion-weighted imaging with ADC maps, and dynamic contrast-enhanced sequences when clinically indicated and not contraindicated.
Treatment groups
Trial outcomes
Primary outcomes
Diagnostic accuracy of MRI in characterization of adnexal cystic lesions
Assessment of the diagnostic performance of magnetic resonance imaging (MRI) in differentiating benign from malignant adnexal cystic lesions, using histopathology, intraoperative findings, or follow-up imaging as the reference standard. Diagnostic accuracy will be expressed in terms of sensitivity, specificity, and predictive values.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: